Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT 1A Agonist, in Patients With Parkinson Disease Psychosis
Stuart Isaacson, Larry B. Goldstein, Rajesh Pahwa, et al.
Neurology Clinical Practice (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 15

Showing 15 citing articles:

Molecular basis of human trace amine-associated receptor 1 activation
Gregory Zilberg, Alexandra Kalia Parpounas, Audrey L. Warren, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis
Manit Srisurapanont, Chawisa Suradom, Sirijit Suttajit, et al.
General Hospital Psychiatry (2024) Vol. 87, pp. 124-133
Closed Access | Times Cited: 10
Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
Spyridon Siafis, Virginia Chiocchia, Malcolm Macleod, et al.
Wellcome Open Research (2024) Vol. 9, pp. 182-182
Open Access | Times Cited: 8
Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
Letizia Biso, Marco Carli, Marco Scarselli, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 85-85
Open Access | Times Cited: 1
AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1
Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo, et al.
Science Advances (2024) Vol. 10, Iss. 32
Open Access | Times Cited: 7
Non-motor Symptoms and Treatments in Parkinson’s Disease
Jennifer G. Goldman
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 291-317
Closed Access
Experimental Therapeutics in Parkinson’s Disease
Priti Gros, Luis Elías Galicia García, Susan H. Fox
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 399-426
Closed Access
Trace amine signaling in zebrafish models: CNS pharmacology, behavioral regulation and translational relevance
David S. Galstyan, Natalia A. Krotova, A. S. Lebedev, et al.
European Journal of Pharmacology (2025), pp. 177312-177312
Closed Access
Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders
Savelii R. Kuvarzin, Ilya Sukhanov, Kirill Onokhin, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1977-1977
Open Access | Times Cited: 11
The pharmacological management of the behavioral aspects of Parkinson’s disease: an update
Marta Campagnolo, Aron Emmi, Roberta Biundo, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 15, pp. 1693-1701
Closed Access | Times Cited: 8
Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies.
Spyridon Siafis, Robert A. McCutcheon, Virginia Chiocchia, et al.
Wellcome Open Research (2023) Vol. 8, pp. 365-365
Open Access | Times Cited: 7
Discovery of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach
Vasavi Garisetti, Anantha Krishnan Dhanabalan, D. Gayathri
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130528-130528
Closed Access | Times Cited: 2
Unlocking the secrets of trace amine-associated receptor 1 agonists: new horizon in neuropsychiatric treatment
Britto Shajan, Tarun Bastiampillai, Shane D. Hellyer, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem)
Kh. I. Alizade, A. A. Ragimova, E. Yu. Fedotova, et al.
Neurology neuropsychiatry Psychosomatics (2024) Vol. 16, Iss. 3, pp. 123-129
Open Access | Times Cited: 1
Trace amine-associated receptor 1 (TAAR1): an emerging therapeutic target for neurodegenerative, neurodevelopmental, and neurotraumatic disorders
Saher Dalvi, Lokesh Kumar Bhatt
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Page 1

Scroll to top